Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2016

Muller Fabbri's Biography



Muller Fabbri, Assistant Professor, University of Southern California

Muller Fabbri is currently Assistant Professor of Pediatrics and Molecular Microbiology & Immunology at the Children’s Center for Cancer and Blood Diseases and Norris Comprehensive Cancer Center of Children’s Hospital Los Angeles and the University of Southern California, Los Angeles, California, USA. He received his M.D. degree in 1997 from the University of Pisa, Italy. He trained at Thomas Jefferson University, Philadelphia, Pennsylvania, USA first and then at the Ohio State University, Columbus, Ohio, USA where he started his research on the role of microRNAs and other non-coding RNAs in cancer. In particular, he was the first to identify a family of miRNAs (the miR-29 family) able to affect DNA methyltransferases and induce re-expression of epigenetically silenced tumor suppressor genes. In 2009 he was awarded a Sidney Kimmel Foundation Fellowship. He has recently identified a completely new mechanism of action of miRNAs: as ligands and agonists of Toll-like receptors, and modulators of tumor growth and dissemination through this aberrant cross-talk between cancer and immune cells within the tumor microenvironment.

Muller Fabbri Image

Role of Exosomic microRNAs in the Biology of the Tumor Microenvironment

Friday, 30 September 2016 at 17:30

Add to Calendar ▼2016-09-30 17:30:002016-09-30 18:30:00Europe/LondonRole of Exosomic microRNAs in the Biology of the Tumor MicroenvironmentLiquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Exosomes and other Extracellular Vesicles are gaining increasing interest for their role in shaping the biology of the tumor microenvironment. Recently, we showed that microRNAs contained in exosomes released by cancer cells are able to bind to Toll-like Receptors in surrounding Tumor-Associated Macrophages, leading to increased cancer growth and resistance to chemotherapy. This novel mechanism of action of microRNAs reveals a fascinating new aspect of the biology of the Tumor Microenvironment and identified exosomic microRNAs as potential new molecular target for anti-cancer therapy.


Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2016Liquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com